C. Conrad

5.8k citations

80 papers · 4.3k · 1 hit paper · h-index 30

Impact in

Genetics top 1%
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
Pulmonary and Respiratory Medicine top 1%
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research

Papers in

Pulmonary and Respiratory Medicine 32
- Cystic Fibrosis Research Advances 17
- Neonatal Respiratory Health Research 9
Surgery 23
- Transplantation: Methods and Outcomes 20

Co-authors: Terence R. Flotte (10 shared papers)William B. Guggino (8 shared papers)John A. Williams (2 shared papers)Richard B. Moss (8 shared papers)Sandra Afione (4 shared papers)Rabindra Tirouvanziam (6 shared papers)Pamela L. Zeitlin (4 shared papers)Leonore A. Herzenberg (4 shared papers)
Journals: Journal of Clinical Oncology (10 papers)The Journal of Heart and Lung Transplantation (6 papers)Pediatric Transplantation (6 papers)Proceedings of the National Academy of Sciences (4 papers)Human Gene Therapy (4 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

C. Conrad

77 papers receiving 4.2k citations

C. Conrad's Hit Papers

align trajectories log scale

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. 1993 · 402 citations

Peers

Countries citing papers authored by C. Conrad

Since Specialization

Citations

This map shows the geographic impact of C. Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Conrad more than expected).

Fields of papers citing papers by C. Conrad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Conrad. The network helps show where C. Conrad may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Conrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Conrad Line = papers co-authored together C. Conrad links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proceedings of the National Academy of Sciences ·Terence R. Flotte, Sandra Afione, C. Conrad, Sharon McGrath, Rikki Solow, Hideki Oka, Pamela L. Zeitlin, William B. Guggino, B J Carter Hit paper breakdown →	1993	402
2	A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo Oncogene ·Arifumi Iwamaru, Sławomir Szymański, Eiji Iwado, Hiroshi Aoki, Tomohisa Yokoyama, Izabela Fokt, Kenneth R. Hess, C. Conrad, Timothy Madden, Raymond Sawaya, Seiji Kondo, Waldemar Priebe, Yasuko Kondo	2006	315
3	Regulation of gastric emptying in humans by cholecystokinin. Journal of Clinical Investigation ·Rodger A. Liddle, Eugene Morita, C. Conrad, John A. Williams	1986	219
4	A Phase II, Double-Blind, Randomized, Placebo-Controlled Clinical Trial of tgAAVCF Using Maxillary Sinus Delivery in Patients with Cystic Fibrosis with Antrostomies Human Gene Therapy ·John A. Wagner, Ilynn B. Nepomuceno, Anna H. Messner, Mary Lynn Moran, Eric P. Batson, Sue Dimiceli, Byron W. Brown, Julie K. Desch, Alexander Norbash, C. Conrad, William B. Guggino, Terence R. Flotte, Jeffrey J. Wine, Barrie J. Carter, Thomas C. Reynolds, Richard B. Moss, Phyllis Gardner	2002	208
5	A Phase I Study of an Adeno-Associated Virus-CFTR Gene Vector in Adult CF Patients with Mild Lung Disease. Johns Hopkins Children's Center, Baltimore, Maryland Human Gene Therapy ·Terence R. Flotte, Barrie Carter, C. Conrad, William B. Guggino, Thomas Reynolds, Beryl J. Rosenstein, G R Taylor, Sandra M. Walden, Randall C. Wetzel	1996	202
6	High-dose oral N -acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis Proceedings of the National Academy of Sciences ·Rabindra Tirouvanziam, C. Conrad, Teodoro Bottiglieri, Leonore A. Herzenberg, Richard B. Moss, Leonard A. Herzenberg	2006	199
7	Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study Human Gene Therapy ·Terence R. Flotte, Pamela L. Zeitlin, Thomas C. Reynolds, Alison E. Heald, Patty Pedersen, Suzanne E. Beck, C. Conrad, Lois Brass‐Ernst, Margaret Humphries, Kevin Sullivan, Randall C. Wetzel, G R Taylor, Barrie J. Carter, William B. Guggino	2003	180
8	Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat American Journal of Physiology-Gastrointestinal and Liver Physiology ·R.A. Liddle, G. M. Green, C. Conrad, John A. Williams	1986	178
9	In vivo model of adeno-associated virus vector persistence and rescue Journal of Virology ·Sandra Afione, C. Conrad, W.G. Kearns, Srinivas K. Chunduru, Robert J. Adams, Thomas C. Reynolds, W. B. Guggino, Garry R. Cutting, B J Carter, Terence R. Flotte	1996	176
10	Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. PubMed ·C. Conrad, Sharon Allen, Sandra Afione, Thomas C. Reynolds, Suzanne E. Beck, M Fee-Maki, X Barrazza-Ortiz, Robert J. Adams, Frederic B. Askin, B J Carter, William B. Guggino, Terence R. Flotte	1996	165
11	Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety Pediatric Pulmonology ·David E. Geller, Michael W. Konstan, Jeffrey M. Smith, Sarah B. Noonberg, C. Conrad	2007	164
12	Safety and Biological Efficacy of an Adeno‐Associated Virus Vector–Cystic Fibrosis Transmembrane Regulator (AAV‐CFTR) in the Cystic Fibrosis Maxillary Sinus The Laryngoscope ·John A. Wagner, Anna H. Messner, Mary Lynn Moran, Richard Daifuku, Keisuke Kouyama, Julie K. Desch, Sara A. Manley, Alexander Norbash, C. Conrad, Sandra Friborg, Thomas Reynolds, William B. Guggino, Richard B. Moss, Barrie J. Carter, Jeffrey J. Wine, Terence R. Flotte, Phyllis Gardner	1999	161
13	Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways Proceedings of the National Academy of Sciences ·Rabindra Tirouvanziam, Yaël Gernez, C. Conrad, Richard B. Moss, Iris Schrijver, Colleen Dunn, Zoe Davies, Leonore A. Herzenberg, Leonard A. Herzenberg	2008	125
14	Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma Journal of Neuro-Oncology ·John de Groot, Mark R. Gilbert, Ken Aldape, Kenneth R. Hess, Teresa Hanna, Sandra Ictech, Morris D. Groves, C. Conrad, Howard Colman, Vinay K. Puduvalli, Victor A. Levin, W.K. Alfred Yung	2008	89
15	Risk Factors for Small Bowel Bacterial Overgrowth in Cystic Fibrosis Journal of Pediatric Gastroenterology and Nutrition ·Jacqueline Fridge, C. Conrad, Lauren B. Gerson, Ricardo Castillo, Kenneth L. Cox	2007	88
16	A phase I/II trial of single-agent PTK 787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in patients with recurrent glioblastoma multiforme (GBM) Journal of Clinical Oncology ·C. Conrad, Henry S. Friedman, David A. Reardon, James Provenzale, Erica L. Jackson, H. Serajuddin, Dirk Laurent, B. Chen, W.K. Alfred Yung	2004	88
17	Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs Proceedings of the National Academy of Sciences ·Megha Makam, Daisy Diaz, Julie Laval, Yaël Gernez, C. Conrad, Colleen Dunn, Zoe Davies, Richard B. Moss, Leonore A. Herzenberg, Leonard A. Herzenberg, Rabindra Tirouvanziam	2009	79
18	Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial Journal of Cystic Fibrosis ·C. Conrad, James Lymp, Valeria Thompson, Colleen Dunn, Zoe Davies, Barbara A. Chatfield, David P. Nichols, John P. Clancy, Robert L. Vender, Marie E. Egan, Lynne M. Quittell, Peter H. Michelson, Veena B. Antony, Jonathan E. Spahr, Ronald C. Rubenstein, Richard B. Moss, Leonore A. Herzenberg, Christopher H. Goss, Rabindra Tirouvanziam	2014	79
19	Multicenter Evaluation of Infant Lung Function Tests as Cystic Fibrosis Clinical Trial Endpoints American Journal of Respiratory and Critical Care Medicine ·Stephanie D. Davis, Margaret Rosenfeld, Gwendolyn S. Kerby, Lyndia C. Brumback, Margaret Kloster, James D. Acton, Andrew A. Colin, C. Conrad, Meeghan A. Hart, Peter Hiatt, Peter J. Mogayzel, Robin Johnson, Stephanie L. Wilcox, Robert G. Castile	2010	77
20	A Phase I/II Study of tgAAV-CF for the Treatment of Chronic Sinusitis in Patients with Cystic Fibrosis. Stanford University, Stanford, California Human Gene Therapy ·John A. Wagner, Mary Lynn Moran, Anna H. Messner, Richard Daifuku, C. Conrad, Thomas Reynolds, William B. Guggino, Richard B. Moss, Barrie J. Carter, Jeffrey J. Wine, Terence R. Flotte, Phyllis Gardner	1998	74

About C. Conrad

C. Conrad is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Epidemiology, Oncology and Genetics, having authored 80 papers that have together received 4.3k indexed citations. Recurring topics across this work include Transplantation: Methods and Outcomes (20 papers), Cystic Fibrosis Research Advances (17 papers), Respiratory viral infections research (12 papers), Glioma Diagnosis and Treatment (12 papers), Neonatal Respiratory Health Research (9 papers), Virus-based gene therapy research (7 papers), Cancer Treatment and Pharmacology (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Genetics (1.3k citations), Genetics (408 citations), Pulmonary and Respiratory Medicine (1.1k citations), Infectious Diseases (436 citations) and Molecular Biology (1.5k citations). C. Conrad has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Terence R. Flotte, William B. Guggino, John A. Williams, Richard B. Moss, Sandra Afione, Rabindra Tirouvanziam, Pamela L. Zeitlin, Leonore A. Herzenberg, Thomas C. Reynolds and Rodger A. Liddle. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Heart and Lung Transplantation, Pediatric Transplantation, Proceedings of the National Academy of Sciences and Human Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

C. Conrad

Impact in

Papers in i

In The Last Decade

C. Conrad

C. Conrad's Hit Papers

Peers

Countries citing papers authored by C. Conrad

Fields of papers citing papers by C. Conrad

All Works

About C. Conrad

Explore authors with similar magnitude of impact

Papers in